ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

17,527Medicare Part D Prescriptions Filled, Including Refills

Rank: 72 out of 680

$1.14M Total Retail Price of All Prescriptions

Rank: 56 out of 680

505 Patients Receiving at Least One Drug in Part D
86%Patients 65 Years and Older
68% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Louisiana
Lower avg

Schedule Two
Controlled Substances

3% of this provider’s 505 patients filled at least one prescription for a schedule two drug, compared to an average of 3%.

Schedule Three
Controlled Substances

18% of this provider’s 505 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

2% of this provider’s 15,416 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

33% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$65 was the average price of a prescription from this provider, compared to $59 among peers.

Prescriptions per Patient

35 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Louisiana
POTASSIUM CHLORIDE 653 598 1 14
AMLODIPINE BESYLATE 478 399 2 1
FUROSEMIDE 478 458 2 6
NEXIUM 436 396 4 16
HYDROCODONE-ACETAMINOPHEN 426 353 S3 5 4
SIMVASTATIN 409 370 6 3
LEVOTHYROXINE SODIUM 405 381 7 2
OMEPRAZOLE 403 361 8 7
CARVEDILOL 326 290 9 23
LISINOPRIL 290 240 10 5
PRAVASTATIN SODIUM 272 241 11 10
SPIRIVA 271 225 12 70
FLUTICASONE PROPIONATE 263 209 13 41
ZOLPIDEM TARTRATE 251 198 14 17
DIOVAN 251 234 14 31
HYDROCHLOROTHIAZIDE 241 223 16 9
CYMBALTA 233 197 17 46
WARFARIN SODIUM 218 165 18 20
METFORMIN HCL 214 204 19 8
CLOPIDOGREL 204 187 20 26
CRESTOR 185 164 21 25
TRAMADOL HCL 180 165 22 18
GABAPENTIN 174 155 23 15
DIOVAN HCT 171 144 24 55
BYSTOLIC 156 140 25 79
METOPROLOL SUCCINATE 154 136 26 13
METOPROLOL TARTRATE 152 122 27 12
DIGOXIN 151 144 28 58
QUETIAPINE FUMARATE 149 122 29 64
POLYETHYLENE GLYCOL 3350 147 128 30 62
GLIMEPIRIDE 147 145 30 29
NAMENDA 141 141 32 35
BENAZEPRIL HCL 139 135 33 40
PANTOPRAZOLE SODIUM 135 125 34 30
LOSARTAN POTASSIUM 126 109 35 21
JANUVIA 125 114 36 60
CITALOPRAM HBR 125 120 36 22
LANTUS 125 102 36 49
PLAVIX 124 109 39 39
DONEPEZIL HCL 122 122 40 27
PREDNISONE 120 107 41 50
ISOSORBIDE MONONITRATE ER 118 100 42 59
BUSPIRONE HCL 116 87 43 144
ZETIA 108 108 44 87
ATORVASTATIN CALCIUM 104 98 45 11
AMITRIPTYLINE HCL 103 97 R 46 47
ALLOPURINOL 103 97 46 33
SERTRALINE HCL 99 99 48 28
CLONIDINE HCL 95 71 49 36
LACTULOSE 93 81 50 92
VENLAFAXINE HCL ER 91 69 51 101
SYNTHROID 90 90 52 38
TAMSULOSIN HCL 90 73 52 34
LOSARTAN-HYDROCHLOROTHIAZIDE 89 79 54 51
ENALAPRIL MALEATE 88 88 55 65
LYRICA 82 44 56 77
RANITIDINE HCL 82 75 56 56
BUMETANIDE 76 76 58 102
PRAMIPEXOLE DIHYDROCHLORIDE 76 38 58 204
PAROXETINE HCL 69 69 60 76
LOVASTATIN 68 65 61 44
ATENOLOL 68 63 61 19
FINASTERIDE 67 67 63 109
EVISTA 67 67 63 135
SEROQUEL 66 55 65 123
RIVASTIGMINE 65 65 66 309
SYMBICORT 62 51 67 208
FELODIPINE ER 62 50 67 146
IPRATROPIUM BROMIDE 61 54 69 211
EXFORGE 61 61 69 151
FAMOTIDINE 60 46 71 89
MEGESTROL ACETATE 59 59 R 72 88
NYSTATIN 59 48 72 191
FENTANYL 58 37 S2 74 183
FORADIL 57 30 75 441
MIRTAZAPINE 55 55 76 78
PHENYTOIN 54 42 77 354
AMOXICILLIN 54 51 77 111
BENAZEPRIL-HYDROCHLOROTHIAZIDE 53 37 79 164
ROPINIROLE HCL 53 48 79 99
PHENYTOIN SODIUM EXTENDED 53 18 79 115
NASONEX 52 45 82 197
DILTIAZEM 24HR ER 52 52 82 132
TRAZODONE HCL 51 37 84 48
DEXILANT 51 39 84 171
HYDRALAZINE HCL 51 51 84 71
NIFEDIPINE ER 50 50 87 75
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.